Cigna Stock News

Cigna said on Wednesday the percentage of employers paying for obesity drugs has remained flat year-over-year, though the health insurer still sees an uptick in demand for the wildly popular treatments.

BLOOMFIELD, Conn. , Sept. 10, 2025 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) announced that Brian Evanko, President and COO of The Cigna Group, and Ann Dennison, EVP and CFO of the Cigna Group will present at the Morgan Stanley 23rd Annual Global Healthcare Conference today, September 10, 2025, in New York, NY.

5 Relatively Secure And Cheap Dividend Stocks, Yields Up To 9% (Sept. 2025)

OLDWICK, N.J.--(BUSINESS WIRE)-- #insurance--AM Best has assigned a Long-Term Issue Credit Rating (Long-Term IRs) of “bbb+” (Good) to The Cigna Group's (Cigna) (headquartered in Bloomfield, CT) [NYSE: CI] new senior unsecured notes. In addition, AM Best has assigned indicative Long-Term IRs on the recently filed shelf registration of Cigna. The outlook assigned to these Credit Ratings (ratings)...

Cigna Group's unit Evernorth Health on Tuesday said it is investing $3.5 billion in specialty pharmacy company Shields Health.

Investment Further Enhances Evernorth's Participation in  Growing Market for Specialty Medicine  BLOOMFIELD, Conn. , Sept. 2, 2025 /PRNewswire/ -- Evernorth Health Services ("Evernorth"), a subsidiary of The Cigna Group (NYSE: CI), today announced a $3.5 billion investment in Shields Health Solutions ("Shields" or the "Company"), a leading specialty pharmacy management company.

Cigna's stock drop after Q2 2025 is overdone; shares now trade at a 15% discount to their 5-year average, creating a compelling entry point. Despite mixed Q2 results and lower profit growth forecasts, my DCF model supports a fair value of $315 per share, implying 8.5% upside. Aggressive share buybacks and steady dividend growth enhance shareholder returns, while Cigna maintains strong cash flow...

Cigna offers a lower-risk profile after selling its Medicare business, avoiding Medicare headwinds impacting peers like UnitedHealth Group. However, the stock price has fallen alongside UNH. Recent earnings were strong, guidance was affirmed, and valuation is attractive, with Wall Street seeing up to 35% upside potential. Risks remain from medical inflation and PBM regulatory scrutiny, but Cign...